glp 1 and hs GLP-1 Receptor Agonists Improve in Patients With Obesity GLP-1 drugs linked to reduced

Membership Question

The best-fit patients for GLP-1 RAs are those with ASCVD with a high risk of future stroke (e.g., with history of stroke or revascularization, or with evidence of significant artery narrowing)

More Energy and Better Focus: Wave goodbye to brain fog and hello to mental clarity and sustained energy

Without coverage, brand-name tirzepatide may cost over $1,000 per month

ZEPBOUND has demonstrated greater weight loss than WEGOVY, giving it a commercial edge in GLP-1 weight loss research

At Soza Clinic, we combine medication-based weight loss with delicious meal plans and education to help you understand your body and its response to our treatments